More Than 3.8 Million U.S. Lung Cancer Deaths Averted During 1970 to 2022
By Elana Gotkine HealthDay Reporter
TUESDAY, April 1, 2025 -- More than 3.8 million U.S. lung cancer deaths were averted during 1970 to 2022, and more than 76 million person-years of life were gained, according to a study published online March 25 in CA: A Cancer Journal for Clinicians.
Farhad Islami, M.D., Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the number of averted lung cancer deaths and corresponding person-years of life gained during 1970 to 2022 in the United States. Data from the National Center for Health Statistics were used to calculate the expected number of deaths; the number of averted cancer deaths was calculated by subtracting the observed from the expected number of deaths.
The researchers estimated that during 1970 to 2022, 3,856,240 lung cancer deaths were averted (2,246,610 in men and 1,609,630 in women) and 76,275,550 person-years of life were gained (40,277,690 in men and 35,997,860 in women), with an average of 19.8 person-years of life gained per death averted (17.9 and 22.4 person-years in men and women, respectively). The number of averted lung cancer deaths accounted for more than half (51.4 percent) of the estimated declines in overall cancer deaths and was greater in men than women (60.1 versus 42.7 percent). The corresponding proportion was 53.6 percent in the White population (62.8 and 44.6 percent in men and women, respectively) and 40.0 percent in the Black population (44.4 and 34.7 percent in men and women, respectively).
"The substantial estimated numbers of averted lung cancer deaths and person-years of life gained highlight the remarkable effect of progress against smoking on reducing premature mortality from lung cancer," Islami said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Immune Checkpoint Inhibitor Affordability Tied to Widening Survival Disparity
FRIDAY, July 11, 2025 -- The introduction of immune checkpoint inhibitors (ICIs) was associated with a widening survival disparity between those with private insurance and those...
Consistent Physical Activity Linked to Reduced All-Cause, CVD Mortality
FRIDAY, July 11, 2025 -- Consistently and increasingly accumulated physical activity (PA) is associated with a reduced risk for all-cause and cardiovascular disease (CVD)...
Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
THURSDAY, July 10, 2025 -- Use of cannabidiol (CBD) within the range consumers are taking with unregulated CBD products is associated with increased liver enzyme levels, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.